Hereditary syndromes and diseases

Role of heredity and environmental factors

The development of any pathology depends on the interaction between the genetic apparatus and exogenous triggers. Based on the ratio of these factors, all diseases are divided into four groups:

• Hereditary forms proper. These are a direct consequence of mutations and develop independently of external conditions.
• Ecogenetic diseases. They manifest under the influence of a specific environmental factor that triggers a genetic defect.
• Diseases of genetic predisposition (multifactorial). Altered genes act here merely as a risk factor. The clinical manifestation of the disease requires an additional environmental impact.
• Diseases caused by environmental factors. The contribution of genetics is minimal or absent. Pathogens include physical factors (thermal factors, ionizing radiation, atmospheric pressure drops, explosive decompression) and chemical exposures (exo- and endogenous intoxications, substance abuse, alcoholism).

Classification by scale of damage

Depending on the volume of affected genetic material, hereditary pathologies are divided into three major groups.

1. Gene disorders The most frequent form, represented predominantly by monogenic (Mendelian) pathologies. They are based on a point mutation that disrupts the synthesis of structural, receptor proteins, or transmembrane carriers. A special group consists of enzymopathies — conditions characterized by impaired enzyme synthesis. Types of inheritance of monogenic pathologies:

• Autosomal dominant (Marfan syndrome, Huntington's chorea, polydactyly).
• Autosomal recessive (cystic fibrosis, phenylketonuria, albinism). Notably, in heterozygotes, the phenotype may be completely normal.
• X-linked (hemophilia, color blindness).
• Holandric (transmitted through the male line via the Y chromosome).
• Mitochondrial (mtDNA mutations, inherited exclusively from the mother).

2. Chromosomal disorders Associated with changes in the number or structure of chromosomes due to impaired segregation during gametogenesis.

• Autosomal anomalies: Down syndrome (trisomy 21), Patau syndrome (trisomy 13), Edwards syndrome (trisomy 18).
• Sex chromosome anomalies: Turner syndrome (karyotype 45, X0) and Klinefelter syndrome (47, XXY).

3. Genomic disorders Severe disorders in the number of entire chromosomal sets (haploidy, polyploidy).

Clinical outcomes of mutations

The clinical significance of mutations is assessed by their impact on organism viability and reproductive capacity. According to the severity of consequences, the following are distinguished:

1. Lethal mutations: lead to fetal death during intrauterine formation (these include haploidy, autosomal monosomies, and many polyploidies).
2. Sublethal mutations: lead to the patient's death before the onset of puberty, making transmission of the mutation to offspring impossible (Swiss-type agammaglobulinemia, Louis-Bar syndrome, severe variants of hemophilia).
3. Hypogenital mutations: physical life is preserved, but the pathology is inevitably accompanied by infertility (characteristic of Turner and Klinefelter syndromes).

Principles of therapy, prevention, and screening

To assist patients with hereditary defects, various levels of intervention are applied:

• Symptomatic: aimed at relieving the condition and halting manifestations.
• Pathogenetic: interruption of disease development mechanisms. Includes specialized dietary therapy (in phenylketonuria), replacement therapy (administration of blood clotting factors or insulin), as well as methods for toxin elimination.
• Etiological: promising areas of gene therapy and engineering capable of eliminating the defect itself at the DNA level.

The foundation of prevention remains medical genetic counseling, protection against mutagens, and prenatal diagnostics. Genetic and laboratory screening are widely used in clinical practice. For example, to determine the causes of thrombosis, thrombophilia markers are investigated (mutations in the factor V Leiden gene, prothrombin gene G20210A, antithrombin III deficiency, protein C and S deficiency), and genetic testing for rare vasculopathies (Fabry disease, Ehlers-Danlos syndrome type IV, FOXC1, COL4A1 gene mutations) is performed.

Class and exam questions

What else to study on this topic

• Mechanisms of genocopy and phenocopy formation
• Cellular natural antimutagenic defense systems
• Pathogenesis of radiation sickness and consequences of ionizing radiation
• Constitutional types and constitutional anomalies as risk factors
• Outpatient genetic screening in autoimmune diseases

Other topics in the "Additional Topics" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.